Therapeutic methods and pharmaceutical compositions for treating acute lung injury and acute respiratory distress syndrome in a human subject are described. The therapeutic methods include administering an amount of a compound effective to selectively inhibit Bruton's tyrosine kinase, but not interleukin-2-inducible T-cell kinase, in the human subject.
展开▼